ISTH Bleeding Assessment Tool (ISTH-BAT)
ISTH/SSC Bleeding Assessment Tool: a standardised bleeding history for suspected inherited bleeding disorders (von Willebrand disease, platelet function disorders, factor deficiencies). Abnormal bleeding score: ≥ 4 in adult men, ≥ 6 in adult women, ≥ 3 in children.
Score interpretation
Within the normal range for children (0–2), adult men (0–3) and adult women (0–5).
→ No further haematological work-up for bleeding symptoms alone; investigate if a family history or laboratory finding raises suspicion.
Abnormal for children (≥ 3); within the normal range for adult men and women.
→ Child: refer to haematology (von Willebrand disease, platelet function disorder, factor deficiency). Adult: interpret with the clinical picture.
Abnormal for adult men (≥ 4) and children; within the normal range for adult women (0–5).
→ Men and children: refer to haematology for bleeding-disorder investigation. Women: interpret with the clinical picture.
Above the normal range for adult men, adult women and children.
→ Refer to haematology; investigate for von Willebrand disease, platelet function disorder or coagulation factor deficiency.
Interpretation bands for the ISTH-BAT. Apply clinical judgement and local guidance.
References
- Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063-2065.
- Elbatarny M, Mollah S, Grabell J, et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831-835.
Related
Curated clinical cross-links plus same-class fallbacks.
- Risperidone (Paediatric) · Atypical Antipsychotic — Autism Spectrum Disorder / Schizophrenia / Tic Disorders
- Vasopressin / Terlipressin · Vasopressin Analogue — Vasodilatory Shock / Variceal Bleeding
- Von Willebrand factor (Specialist drug) · Plasma-derived or recombinant vWF concentrate
- Tetrabenazine · VMAT2 Inhibitor — Hyperkinetic Movement Disorders
- Nusinersen · Rare Neurological Disorders
- Daridorexant · Sleep Disorders
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.